BIBLIOGRAFÍA DE INTERÉS

Arias, M., Moyano M., Escribano, J.M. y Sánchez-Vizcaíno. (1992). Evaluation of two ELISA kits for the detection of Aujeszky's disease antibodies pigs. Vet. Rec. 131, 391-393.

Bouma, A; De Jong,MCM; Kimman, TG.(1997). The influence of maternal immunity on the transmission of pseudorabies virus and on the effectiveness of vaccination. Vaccine, 15, 287-294.

De Leeuw,PW; Van Oirschot,JT (1985). Vaccines against Aujeszky's disease: evaluation of their efficacy under standardized laboratory conditions, Vet. Q.7, 191-197.

De Smet, K; De Wahle, K; Pensaert, M. (1994). Influence of vaccine medium and vaccination schedules on the induction of active immunity against Aujeszky´s disease in maternally immune pigs. Res. Vet. Sci., 56,89-94.

Del Pozo, M; Pallas, R. (2001). The Pig Journal vol. 47, 67-73.

Firkins, LD; Weigel, RM; Biehl, LG; Hahn, EC (1997). Field trial to evaluate the immunogenicity of pseudorabies virus vaccines with deletions for glycoproteins G and E, Am J. Vet. Res 58, 976-984.

Jacobs, L. (1994). Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae. Arch. Virol, 137, 209-228.

Jacobs, L; Mulder, W; Dercksen, D; Vos, J; Raymakers, R; Kimman, T. (1997). Detection of wild-type Aujeszky´s disease virus by polymerase chain reaction in sheep vaccinated with a modified live vaccine strain. Res. Vet. Sci., 62, 271-274.

Kimman, TG; De Bruin, TMG; Voermans, JJM; Peeters, BPH; Bianchi, ATJ (1995) Development and antigen specificity of the lymphoproliferation response of pigs to pseudorabies virus: dichotomy between secondary B- and T-cell responses. Immunol., 86, 372-378.

Kimman, TG; Gielkens, ALJ; Glazenburg, K; Jacobs, L; De Jong, BPH. (1995).Characterization of live pseudorabies virus vaccines. Dev. Biol. Stand. Karger, 84, 89-96.

Kluge, JP; Beran, GW; Hill, HT; Platt, KB. (1999) Pseudorabies (Aujeszky´s disease). En: Diseases of Swine, 8ª edición. A.D. Leman, B.E. Straw, W.L. Mengeling, S. Dáillaire, D.S. Taylor, editores. Iowa State University Press, Ames (IA): 233-246.

Marchioli, CC; Yancey, RJ; Wardley, RC; Thomsen,DR; Post,LE. (1987). A vaccine strain of pseudorabies virus with deletions in the thymidine kinase and glycoprotein X genes. Am.J.Vet. Res., 48, 1577-1583.

Mengeling, WL; Lager, KM; Volz, DM; Brockmeier, SL; (1992). Effect of various vaccination procedures on shedding, latency and reactivation of attenuated and virulent pseudorabies virus in swine. Am. J.Vet. Res., 53, 2164-2173.

Mettenleiter, TC. (1996). Immunobiology of pseudorabies (Aujeszky´s disease). Veterinary Immunology and Immunopathology 54, 221-229.

Mettenleiter, TC (2000). Aujeszky´s disease (Pseudorabies) virus: the virus and molecular pathogenesis- State of the art, June 1999. Vet. Res. 31, 99-115.

Ober, BT; Summerfield, A; Mattlinger, C; Weismuller, KH; Jung, g; Pfaff, E; Saalmuller, A; Rziha, HJ (1998). Vaccine induced, pseudorabies virus-specific, extrathymic CD4+ CD8+ memory T-helper cells in swine. J. Virol. 72, 4866-4870.

Ohlinger, VF; Pesch, S; Hense, I. (2000). Non-vaccinated subpopulations play a major role in reinfections during eradication programs based on regular vaccination against Aujeszky´s disease virus. Vet. Res. 31, 147-148.

Sánchez-Vizcaíno, JM. (2001). Curso de Introducción a la Inmunología porcina. http://www.sanidadanimal.info/inmuno/inicio.htm

Schang, LM; Kutish, GF; Osorio, FA. (1994). Correlation between precolonization of trigeminal ganglia by attenuated strains of Pseudorabies virus and resistance to wild-type virus latency. J. Virol, 68, 8470-8476.

Stegeman, JA; Kimman, TG; Van Oirschot, JT; Tielen, MJ; Hunneman, WA (1994a). Spread of Aujeszky's disease virus within pig herds in an intensively vaccinated region, Vet. Rec. 134, 327-330.

Stegeman,JA; Tielen, MJ; Kimman, TG; Van Oirschot, JT; Hunneman, WA; Berndsen, FW (1994b). Intensive regional vaccination with a gI-deleted vaccine markedly reduces pseudorabies virus infections, Vaccine 12, 527-531.

Stegeman, A; Van Nes, A; De Jong, MCM; Bolder, FW. (1995). Assessment of the effectiveness of vaccination against pseudorabies in finishing pigs. Am.J. Vet. Res., 56, 573-578.

Van Nes, A; De Jong, MCM; Verheijden, JHM. (2000). Modelling pseudorabies virus infection supports eradication. Vet. Res. 31, 149-150.

Van Oirschot, JT; De Leeuw, PW (1985). Intranasal vaccination of pigs against Aujeszky's disease.a. Comparison with one or two doses of an inactivated vaccine in pigs with moderate maternal antibody titres, Vet. Microbiol. 10. 401- 408.

Van Oirschot, JT. (1989). Vaccination and Control of Aujeszky´s disease. Kluwer Academic Publishers.

Van Rooij, EMA; Haagmans, BL; Glansbeek, HL; De Visser, YE; Boersma, W; Bianchi, ATJ. (2000). DNA vaccine coding for glycoprotein B of PRV induces cytotoxic T cell responses in pigs against PRV. Vet. Res, 31, 132-133.

Vannier,P. (1985). Experimental infection of fattening pigs with pseudorabies (Aujeszky´s disease) virus: Efficacy of attenuated live-and inactivated-virus vaccines in pigs with or without passive immunity. Am. J. Vet. Res. 46, 1498-1502.

Vilnis, A; Sussman M; Thacker,BJ; Senn, M; Maes, RK.( 1998). Vaccine genotype and route of administration affect pseudorabies field virus latency load after challenge.Vet.Microbiol, 62, 81-96.

Visser, N. (1997). Vaccination strategies for improving the efficacy of programs to eradicate Aujeszky´s disease virus. Vet. Microbiol. 55, 61-74.

Wesley, RD; Cheung, AK. (1996). A pseudorabies virus mutant with deletions in the latency and early protein O genes: replication, virulence, and immunity in neonatal piglets. J Vet Diagn Invest. 8, 21-24.

Wheeler, G; Osorio, FA. (1991). Investigation of sites of pseudorabies virus latency using polymerase Caín reaction. Am. J. Vet. Res., 52, 1799-1803.

Zuckermann, FA; Husmann, RJ; Schwartz, R; Brandt, J; Mateu de Antonio, E; Martin,S (1998). Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs. Vet. Immunol. Immunopathol. 66, 113-117.

Zuckermann, FA. (2000). Aujeszky´s disease virus:opportunities and challenges. Vet. Res., 31,121-131.

« 9. Prevención, profilaxis, control y erradicación